Tech Company Financing Transactions
Aires Pharmaceuticals Funding Round
Aires Pharmaceuticals secured a $6 million venture capital round on 3/31/2012. Investors included MPM Capital and private investors.
Transaction Overview
Company Name
Announced On
3/31/2012
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
MPM Capital (William Greene)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
4365 Executive Dr. 1500
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
As a first product opportunity, the Company is developing an inhaled drug that has been demonstrated in animal models to treat both adult and pediatric pulmonary hypertension. As a second product opportunity, Aires is also pursuing indications associated with the treatment of bacterial pulmonary infections.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Wendy Johnson
Chief Medical Officer
Edwin Parsley
VP - Finance
Julie Crawford
VP - Product Management
Hiroko Masamune
Browse more venture capital transactions:
Prev: 3/31/2012: BurstPoint Networks venture capital transaction
Next: 3/31/2012: 3dna venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs